| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $1.4B | $1.5B | $1.6B | $1.8B | $1.4B | $0.9B | $0.2B | $0.2B |
| Net Income | $1.0B | $1.2B | $1.2B | $1.4B | $1.0B | $0.7B | $0.1B | $0.2B |
| EPS (Basic) | $4.86 | $5.51 | $11.33 | $12.26 | $8.94 | $5.71 | $1.81 | $1.96 |
| EPS (Diluted) | $4.84 | $5.48 | $11.26 | $12.18 | $8.89 | $5.68 | $1.80 | $1.95 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.5B | $5.5B | $5.5B | $4.8B | $4.8B | $4.4B | $4.0B | $3.5B |
| Current Assets | $0.7B | $0.7B | $1.1B | $0.9B | $1.4B | $1.2B | $0.9B | $0.7B |
| Cash & Equivalents | $0.1B | $0.1B | $0.4B | $0.2B | $0.5B | $0.4B | $0.4B | $0.2B |
| Total Liabilities | $1.2B | $1.2B | $1.3B | $1.2B | $1.1B | $1.0B | $0.9B | $0.9B |
| Current Liabilities | $0.5B | $0.5B | $0.5B | $0.5B | $0.5B | $0.4B | $0.4B | $0.4B |
| Stockholders' Equity | $4.3B | $4.2B | $4.3B | $3.7B | $3.7B | $3.3B | $3.1B | $2.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.4B | $1.7B | $1.6B | $1.7B | $1.2B | $0.9B | $1.0B | $0.9B |
| Investing Cash Flow | $-0.4B | $-0.8B | $-0.7B | $-0.5B | $-0.5B | $-0.6B | $-0.5B | $-0.6B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-1.0B | $-1.2B | $-0.7B | $-1.4B | $-0.7B | $-0.4B | $-0.3B | $-0.3B |